Browse by Poster Presenter

Skip to main content

ICPE 2021 Main banner

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

O
Oatman, Logan

University of Kentucky College of Pharmacy
(P-485) Predictors of Concomitant Use of Opioids and Gabapentin in the National Alzheimer's Coordinating Center Database
Logan Oatman
Favorite
Obidi, Joyce

CBER, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
(P-060) Post-keratoplasty Fungal Keratitis in the Sentinel Distributed Database: Prevalence and Time Trends
Joyce Obidi
Favorite
O'Cleirigh, Conall

Harvard University
(P-037) Vaporized Nicotine (E-cig) Use Among People with HIV in Care in the US
Conall O'Cleirigh
Favorite
Oelofse, Diana

Drug Utilization Research Unit (DURU), Nelson Mandela University
(P-014) Dispensing Patterns of Antithrombotic Agents in South Africa with Specific Focus on the Direct Oral Anticoagulants (DOACs): A Database Analysis
Diana Oelofse
Favorite
Oerlemans, Dennis

Laurentius Hospital
(P-486) Diabetes Medication Use Is Associated with Higher Grade and Increased Probability of Muscle-invasive Tumour Disease in Patients with Urothelial Carcinoma
Dennis Oerlemans
Favorite
Offredo, Lucile

EPI-PHARE (French National Agency for Medicines and Health Products Safety -ANSM- and French National Health Insurance -CNAM-), Saint-Denis, France
(P-439) Paediatric Outpatient Prescriptions in Countries with Advanced Economies in the 21st Century: A Systematic Review and an International Comparison
Lucile Offredo
Favorite
Ogilvie, Rachel

Optum Epidemiology
(P-206) Pediatric Fentanyl Overdose Within an Electronic Health Record Database
Rachel Ogilvie
Favorite
(P-207) Trends in Administered Medication Use Among Patients Hospitalized with COVID-19 in the United States
Rachel Ogilvie
Favorite
(P-531) Role of D-dimer on Serious Outcomes Among Patients Hospitalized with COVID-19
Rachel Ogilvie
Favorite
(P-577) Clinical Characteristics of Pediatric Patients Hospitalized with COVID-19 in an Electronic Health Record Database
Rachel Ogilvie
Favorite
Ogunleye, Olayinka

Departments of Pharmacology and Medicine, Lagos State University College of Medicine & Lagos State University Teaching Hospital
(P-011) Drug Utilization Research in Africa: overview of Demographic and Socioeconomic Profile, Health Systems and Epidemiology
Olayinka Ogunleye
Favorite
Ogura, Eriko

Shionogi & Co., Ltd.
(P-017) Comparison of the Incidence of Bleeding Between Anti-influenza Drugs Among Outpatients for the Influenza Virus Infection: A Retrospective Study Using an Employment-based Health Insurance Claims Database in Japan
Eriko Ogura
Favorite
Oh, GYeon

University of Kentucky College of Pharmacy
(P-097) Characterizing Patients Using Abuse-deterrent Formulations of Extended-release Opioid Analgesics
GYeon Oh
Favorite
(P-353) Matching Study Design to Prescribing Intention: The Prevalent New User Design in Opioid Research
GYeon Oh
Favorite
(P-485) Predictors of Concomitant Use of Opioids and Gabapentin in the National Alzheimer's Coordinating Center Database
GYeon Oh
Favorite
Oh, In-Sun

School of Pharmacy, Sungkyunkwan University
(P-523) Temporal Trends of Pharmacologic Treatments for tuberculosis and Multidrug-resistant tuberculosis Following Treatment Guideline Dissemination in South Korea
In-Sun Oh
Favorite
(P-621) Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients with Type 2 Diabetes
In-Sun Oh
Favorite
Okala, Sandra

Evidera
(P-069) Improving Accuracy for Prospective Pregnancy Registry Enrollment Targets
Sandra Okala
Favorite
OKALEBO, PROF. FAITH

University of Nairobi
(P-153) Patterns of Meropenem Utilization and Resistance at a Kenyan Public Referral Hospital
PROF. FAITH OKALEBO
Favorite
Okobi, Margaret

Harvard Medical School
(P-384) Temporal Changes in the Baseline Patient Characteristics of COVID-19 Patients
Margaret Okobi
Favorite
Okuyama, Julia

UNIFESP
(P-488) Estimates of Paracetamol Poisoning in Brazil: Analysis of Official Records
Julia Okuyama
Favorite
Olesen, Kevin

Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark
(P-016) Triglyceride Levels in Early Type 2 Diabetes and Their Association with Cardiovascular Risk: A Danish Cohort Study
Kevin Olesen
Favorite
Oleske, Denise

AbbVie
(P-522) Early Parkinson’s Disease: Association of Baseline Fatigue, Pain and Sleep Disorders with Disease Progression
Denise Oleske
Favorite
Olfson, Mark

Columbia University
(P-350) Overdose Risk Following Prescription Benzodiazepine Treatment in Young People
Mark Olfson
Favorite
(P-507) Suicide Risk in Schizophrenia Across the Lifespan
Mark Olfson
Favorite
Olié, Valérie

Santé Publique France
(P-178) Patterns of Antihypertensive Drugs Use After Primary Stroke in the General Population
Valérie Olié
Favorite
Olsen, Anne Helene

Novo Nordisk A/S
(P-335) Pilot Study Rectifies Real World Study Design to Support Regulatory Decision Making
Anne Helene Olsen
Favorite
Olsen, Kristine

Norwegian Institute of Public Health
(P-310) Hypnotic Drug Use and Underlying Diagnoses Among Adolescents in Norway
Kristine Olsen
Favorite
OLUKA PhD, DR. MARGARET

University of Nairobi
(P-153) Patterns of Meropenem Utilization and Resistance at a Kenyan Public Referral Hospital
DR. MARGARET OLUKA PhD
Favorite
Onasanya, Oluwadamilola

University of Maryland School of Pharmacy
(P-114) Comedication of Opioids with Benzodiazepines, Gabapentinoids Among Caregivers of Children with Special Healthcare Needs
Oluwadamilola Onasanya
Favorite
(P-636) Risk of Acute Respiratory Failure Among Non-elderly Patients with Solid Tumors Receiving Pegfilgrastim and Concomitant Opioids: A Nested Case-control Study
Oluwadamilola Onasanya
Favorite
Onukwugha, Eberechukwu

University of Maryland School of Pharmacy
(P-636) Risk of Acute Respiratory Failure Among Non-elderly Patients with Solid Tumors Receiving Pegfilgrastim and Concomitant Opioids: A Nested Case-control Study
Eberechukwu Onukwugha
Favorite
Orwig, Denise

University of Maryland, Baltimore, Department of Epidemiology and Public Health, Division of Gerontology
(P-189) Low Rates of Bone-active Medication Utilization from 2013-2017 by Provider Type for Beneficiaries Aged 65+ with Medicare Part D
Denise Orwig
Favorite
Osborne, Vicki

Drug Safety Research Unit, Southampton, UK
(P-389) Utilisation and Safety of Glycopyrronium Bromide (GPB) Oral Solution for the Treatment of Sialorrhoea in Children <18 Years in the UK
Vicki Osborne
Favorite
Osmundson, Sarah

Vanderbilt University Medical Center
(P-537) Temporal and Hospital-level Variation in High-dose Postpartum Opioid Prescribing After Cesarean Delivery
Sarah Osmundson
Favorite
Ouali, Amina

Laval University
(P-244) Polypharmacy Among Older Individuals with Heart Failure: Trends Between 2000 and 2017 in the Province of Quebec, Canada
Amina Ouali
Favorite
Oueini, Razanne

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(P-107) Evaluating the Use of Prescription Sequence Symmetry Analysis as a Pharmacovigilance Tool: A Scoping Review
Razanne Oueini
Favorite
Ou, Huang-Tz

Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
(P-127) Identifying Dipeptidyl peptidase-4 Inhibitor Users with Sufficient Data Completeness in Electronic Health Records
Huang-Tz Ou
Favorite
Overbeek, Jetty

PHARMO Institute
(P-377) Users of Biologics for Crohn’s Disease and Ulcerative Colitis in the Netherlands
Jetty Overbeek
Favorite
(P-486) Diabetes Medication Use Is Associated with Higher Grade and Increased Probability of Muscle-invasive Tumour Disease in Patients with Urothelial Carcinoma
Jetty Overbeek
Favorite
(P-515) Factors Predictive of Treatment Success of Novel Disease-modifying Anti-rheumatic Drugs (DMARDS) in Patients with Inflammatory Arthritis
Jetty Overbeek
Favorite
Owen, Ruth

Oxon Epidemiology
(P-424) Challenges in Studying COVID-19 Treatments in Real-world Hospital Datasets: A Case Study of Tocilizumab
Ruth Owen
Favorite